Founding Pharma Statistics
India - Pharmacy of the World
Most USFDA - compliant plants outside USA
Over 2,000 WHO-GMP approved facilities
Projected Growth
US$ 130 Billion by 2030
National Medical Devices Policy 2023 : US$ 2.04 Billion Outlay
100% FDI - Greenfield Projects
74% FDI - Brownfield Projects
Cost-Efficient R&D
30% - 35% Lower Than US & Europe
87% Lower Than Developed Markets